Aerosol Generation and Mitigation During Methacholine Bronchoprovocation Testing: Infection Control Implications in the Era of COVID-19.

MLA

Subat, Yosuf W., et al. “Aerosol Generation and Mitigation During Methacholine Bronchoprovocation Testing: Infection Control Implications in the Era of COVID-19.” Respiratory Care, vol. 66, no. 12, Dec. 2021, pp. 1858–65. EBSCOhost, https://doi.org/10.4187/respcare.09236.

APA

Subat, Y. W., Hainy, M. E., Torgerud, K. D., Sajgalik, P., Guntupalli, S. K., Johnson, B. D., Kim Chul-Ho, G. Lim, K., Helgeson, S. A., Scanlon, P. D., & Niven, A. S. (2021). Aerosol Generation and Mitigation During Methacholine Bronchoprovocation Testing: Infection Control Implications in the Era of COVID-19. Respiratory Care, 66(12), 1858–1865. https://doi.org/10.4187/respcare.09236

Chicago

Subat, Yosuf W., Matthew E. Hainy, Keith D. Torgerud, Pavol Sajgalik, Siva Kamal Guntupalli, Bruce D. Johnson, Kim Chul-Ho, et al. 2021. “Aerosol Generation and Mitigation During Methacholine Bronchoprovocation Testing: Infection Control Implications in the Era of COVID-19.” Respiratory Care 66 (12): 1858–65. doi:10.4187/respcare.09236.